Personalized medicine and opioid analgesic prescribing for chronic pain: Opportunities and challenges

Journal of Pain

Volumn 14, Issue 2, 2013, Pages 103-113

  Bruehl, Stephen ^a   Apkarian, A Vania ^b   Ballantyne, Jane C ^c   Berger, Ann ^d   Borsook, David ^e   Chen, Wen G ^f   Farrar, John T ^g   Haythornthwaite, Jennifer A ^h   Horn, Susan D ⁱ   Iadarola, Michael J ^j   Inturrisi, Charles E ^k   Lao, Lixing ^l   MacKey, Sean ^m   Mao, Jianren ^e   Sawczuk, Andrea ⁿ   Uhl, George R ^o   Witter, James ^p   Woolf, Clifford J ^e   Zubieta, Jon Kar ^q   Lin, Yu ^o  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ INSTITUTE FOR CLINICAL OUTCOMES RESEARCH   (United States)

^j NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^k WEILL CORNELL MEDICAL COLLEGE   (United States)

^l UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^m STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ NATIONAL INSTITUTES OF HEALTH   (United States)

^o NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^p NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^q UNIVERSITY OF MICHIGAN   (United States)

more..

Author keywords

chronic pain; opioid abuse; Opioid analgesics; personalized medicine; side effects

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BUPRENORPHINE; CYTOCHROME P450 2D6; DOPAMINE; ENDORPHIN; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; NEUROTRANSMITTER; PLACEBO; TAPENTADOL;

ACUPUNCTURE; AEROBIC EXERCISE; AFFECT; ALGORITHM; ALLODYNIA; ANALGESIC ACTIVITY; ARTICLE; BINDING AFFINITY; BRAIN FUNCTION; CHRONIC PAIN; CLINICAL EFFECTIVENESS; CLUSTER HEADACHE; DRUG EFFICACY; DRUG METABOLISM; DRUG POTENTIATION; DRUG RESPONSE; EVIDENCE BASED PRACTICE; FIBROMYALGIA; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEREDITY; HUMAN; HYPERALGESIA; HYPOALGESIA; INFLAMMATORY PAIN; KIDNEY DYSFUNCTION; LOW BACK PAIN; MEDICAL RESEARCH; MODEL; MORTALITY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PERSONALIZED MEDICINE; PHENOTYPE; POLYPHARMACY; PREDICTIVE VALUE; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR BINDING; RECEPTOR UPREGULATION; RELAXATION TRAINING; RISK FACTOR; RNA EDITING; RNA TRANSLATION; SENSITIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDITY;

ANALGESICS, OPIOID; BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CHRONIC PAIN; DRUG PRESCRIPTIONS; DRUG SYNERGISM; GENETIC VARIATION; HUMANS; INDIVIDUALIZED MEDICINE; NEUROTRANSMITTER AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84873304881     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2012.10.016     Document Type: Article

References (126)

1. A.P. Abernethy, A. Ahmad, S.Y. Zafar, J.L. Wheeler, J.B. Reese, and H.K. Lyerly Electronic patient-reported data capture as a foundation of rapid learning cancer care Med Care 48 2010 S32 S38
2. A.P. Abernethy, L.M. Etheredge, P.A. Ganz, P. Wallace, R.R. German, C. Neti, P.B. Bach, and S.B. Murphy Rapid-learning system for cancer care J Clin Oncol 28 2010 4268 4274
3. A.P. Abernethy, J.L. Wheeler, and S.Y. Zafar Detailing of gastrointestinal symptoms in cancer patients with advanced disease: New methodologies, new insights, and a proposed approach Curr Opin Support Palliat Care 3 2009 41 49
4. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons Pharmacological management of persistent pain in older persons J Am Geriatr Soc 57 2009 1331 1346
5. H.I. Andersson The epidemiology of chronic pain in a Swedish rural area Qual Life Res 3 1994 s19 s26
6. M.S. Angst, and J.D. Clark Opioid-induced hyperalgesia: A qualitative systematic review Anesthesiology 104 2006 570 587
7. M.S. Angst, N.G. Phillips, D.R. Drover, M. Tingle, A. Ray, G.E. Swan, L.C. Lazzeroni, and J.D. Clark Pain sensitivity and opioid analgesia: A pharmacogenomic twin study Pain 153 2012 1397 1409
8. A.V. Apkarian Human brain imaging studies of chronic pain: Translational opportunities L. Kruger, A.R. Light, Translational Pain Research: From Mouse to Man 2010 CRC Press Boca Raton, FL
9. L. Arendt-Nielsen, T. Andresen, L.P. Malver, A. Oksche, H. Mansikka, and A.M. Drewes A double-blind, placebo-controlled study on the effect of buprenorphine and fentanyl on descending pain modulation: A human experimental study Clin J Pain 28 2012 623 627
10. M.N. Baliki, D.R. Chialvo, P.Y. Geha, R.M. Levy, R.N. Harden, T.B. Parrish, and A.V. Apkarian Chronic pain and the emotional brain: Specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain J Neurosci 26 2006 12165 12173
11. M.N. Baliki, P.Y. Geha, H.L. Fields, and A.V. Apkarian Predicting value of pain and analgesia: Nucleus accumbens response to noxious stimuli changes in the presence of chronic pain Neuron 66 2010 149 160
12. M.N. Baliki, B. Petre, S. Torbey, K.M. Herrmann, L. Huang, T.J. Schnitzer, H.L. Fields, and A.V. Apkarian Corticostriatal functional connectivity predicts transition to chronic back pain Nat Neurosci 15 2012 1117 1119
13. M.L. Banks, K.C. Rice, and S.S. Negus Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: Role of Mu agonist efficacy J Pharmacol Exp Ther 335 2010 497 505
14. R. Baron, T.R. Tölle, U. Gockel, M. Brosz, and R. Freynhagen A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms Pain 146 2009 34 40
15. A.S. Bohnert, M. Valenstein, M.J. Bair, D. Ganoczy, J.F. McCarthy, M.A. Ilgen, and F.C. Blow Association between opioid prescribing patterns and opioid overdose-related deaths JAMA 305 2011 1315 1321
16. D. Borsook, L. Becerra, and R. Hargreaves Biomarkers for chronic pain and analgesia. Part 2: How, where, and what to look for using functional imaging Discov Med 11 2011 209 219
17. D. Borsook, R. Hargreaves, and L. Becerra Can functional magnetic resonance imaging improve success rates in CNS drug discovery? Expert Opin Drug Discov 6 2011 597 617
18. G. Brattberg, M. Thorslund, and A. Wikman The prevalence of pain in a general population. The results of a postal survey in a county of Sweden Pain 37 1989 215 222
19. J.E. Brown, N. Chatterjee, J. Younger, and S. Mackey Towards a physiology-based measure of pain: Patterns of human brain activity distinguish painful from non-painful thermal stimulation PLoS One 6 2011 e24124
20. S. Bruehl, J.W. Burns, O.Y. Chung, and M. Chont Interacting effects of trait anger and acute anger arousal on pain: The role of endogenous opioids Psychosom Med 73 2011 612 619
21. S. Bruehl, J.W. Burns, O.Y. Chung, and M. Chont What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function? Eur J Pain 2011 Dec 19 [Epub ahead of print]
22. S. Bruehl, O.Y. Chung, P. Ward, and B. Johnson Endogenous opioids and chronic pain intensity: Interactions with level of disability Clin J Pain 20 2004 283 292
23. A. Buvanendran, M. Moric, J.S. Kroin, C. Saha, W. Soong, and K.J. Tuman Geographical variations in oxycodone emergency department visits: A regional stratification of abuse level estimate in USA Anesth Analg 100 2005 S-179
24. D.T. Campbell, and J.C. Stanley Experimental and Quasi-Experimental Designs for Research 1962 Houghton Mifflin Company Boston, MA
25. C.R. Chapman, D.L. Lipschitz, M.S. Angst, R. Chou, R.C. Denisco, G.W. Donaldson, P.G. Fine, K.M. Foley, R.M. Gallagher, A.M. Gilson, J.D. Haddox, S.D. Horn, C.E. Inturrisi, S.S. Jick, A.G. Lipman, J.D. Loeser, M. Noble, L. Porter, M.C. Rowbotham, K.M. Schoelles, D.C. Turk, E. Volinn, M.R. Von Korff, L.R. Webster, and C.M. Weisner Opioid pharmacotherapy for chronic non-cancer pain in the United States: A research guideline for developing an evidence-base J Pain 11 2010 807 829
26. D.B. Chapman, J. Hu, and E.L. Way Methionine-enkephalin antagonism and endorphin potentiation of narcotic-induced analgesia Eur J Pharmacol 65 1980 369 377
27. R. Chou, G.J. Fanciullo, P.G. Fine, C. Miaskowski, S.D. Passik, and R.K. Portenoy Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guidelines J Pain 10 2009 131 146
28. L.F. Chu, D.J. Clark, and M.S. Angst Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study J Pain 7 2006 43 48
29. K.M. Dunn, K.W. Saunders, C.M. Rutter, C.J. Banta-Green, J.O. Merrill, M.D. Sullivan, C.M. Weisner, M.J. Silverberg, C.I. Campbell, B.M. Psaty, and M. Von Korff Opioid prescriptions for chronic pain and overdose: A cohort study Ann Intern Med 152 2010 85 92
30. M.J. Edlund, B.C. Martin, A. Devries, M.Y. Fan, J.B. Braden, and M.D. Sullivan Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: The TROUP study Clin J Pain 26 2010 1 8
31. M.J. Edlund, D. Steffick, T. Hudson, K.M. Harris, and M. Sullivan Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain Pain 129 2007 355 362
32. R.R. Edwards, J.A. Haythornthwaite, P. Tella, M.B. Max, and S. Raja Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia Anesthesiology 104 2006 1243 1248
33. E. Eisenberg, A. Midbari, M. Haddad, and D. Pud Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects Pain 151 2010 104 109
34. T. Eissing, J. Lippert, and S. Willmann Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide: Model-based analysis of the influence of CYP2D6 activity, UGT2B7 activity, renal impairment, and CYP3A4 inhibition Mol Diagn Ther 16 2012 43 53
35. Etheredge LM: A rapid-learning health system. What would a rapid-learning health system look like, and how might we get there? Health Affairs - Web exclusive from contenthealthaffairsorg http://contenthealthaffairsorg/content/ 26/2/w107fullhtml, 2007
36. R. Evans, G. Elwyn, and A. Edwards Making interactive decision support for patients a reality Inform Prim Care 12 2004 109 113
37. G.J. Fanciullo, J.P. Cravero, B.O. Mudge, G.J. McHugo, and J.C. Baird Development of a new computer method to assess children's pain Pain Med 8 Suppl 3 2007 S121 S128
38. H. Fields State-dependent opioid control of pain Nat Rev Neurosci 5 2004 565 575
39. D.A. Fishbain, B. Cole, J. Lewis, H.L. Rosomoff, and R.S. Rosomoff What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review Pain Med 9 2008 444 459
40. C.R. France, M. al'absi, C. Ring, J.L. France, J. Brose, D. Spaeth, A. Harju, G. Nordehn, and L.E. Wittmers Assessment of opiate modulation of pain and nociceptive responding in young adults with a parental history of hypertension Biol Psychol 70 2005 168 174
41. G.M. Franklin, J. Mai, T. Wickizer, J.A. Turner, D. Fulton-Kehoe, and L. Grant Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002 Am J Ind Med 48 2005 91 99
42. A.K. Frew, and P.D. Drummond Negative affect, pain and sex: The role of endogenous opioids Pain 132 Suppl 1 2007 S77 S85
43. K. Fukuda, M. Hayashida, S. Ide, N. Saita, Y. Kokita, S. Kasai, D. Nishizawa, Y. Ogai, J. Hasegawa, M. Nagashima, M. Tagami, H. Komatsu, I. Sora, H. Koga, Y. Kaneko, and K. Ikeda Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery Pain 147 2009 194 201
44. E.L. Gardner Addiction and brain reward and antireward pathways Adv Psychosom Med 30 2011 22 60
45. G.S. Ginsburg, and H.F. Willard Genomic and personalized medicine: Foundations and applications Transl Res 154 2009 277 287
46. T. Gomes, M.M. Mamdani, I.A. Dhalla, J.M. Paterson, and D.N. Juurlink Opioid dose and drug-related mortality in patients with nonmalignant pain Arch Intern Med 171 2011 686 691
47. A.J. Hall, J.E. Logan, R.L. Toblin, J.A. Kaplan, J.C. Kraner, D. Bixler, A.E. Crosby, and L.J. Paulozzi Patterns of abuse among unintentional pharmaceutical overdose fatalities JAMA 300 2008 2613 2620
48. R.E. Harris, D.J. Clauw, D.J. Scott, S.A. McLean, R.H. Gracely, and J.K. Zubieta Decreased central mu-opioid receptor availability in fibromyalgia J Neurosci 27 2007 10000 10006
49. R.E. Harris, J.K. Zubieta, D.J. Scott, V. Napadow, R.H. Gracely, and D.J. Clauw Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs) Neuroimage 47 2009 1077 1085
50. M. Hayashida, M. Nagashima, Y. Satoh, R. Katoh, M. Tagami, S. Ide, S. Kasai, D. Nishizawa, Y. Ogai, J. Hasegawa, H. Komatsu, I. Sora, K. Fukuda, H. Koga, K. Hanaoka, and K. Ikeda Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype Pharmacogenomics 9 2008 1605 1616
51. G. Henriksen, and F. Willoch Imaging of opioid receptors in the central nervous system Brain 131 2008 1171 1196
52. M.K. Ho, D. Goldman, A. Heinz, J. Kaprio, M.J. Kreek, M.D. Li, M.R. Munafò, and R.F. Tyndale Breaking barriers in the genomics and pharmacogenetics of drug addiction Clin Pharmacol Ther 88 2010 779 791
53. S.D. Horn, G. DeJong, and D. Deutscher Practice-based evidence research in rehabilitation: An alternative to randomized controlled trials and traditional observational studies Arch Phys Med Rehabil 93 2012 S127 S137
54. S.D. Horn, G. DeJong, R. Smout, J. Gassaway, R. James, and B. Conroy Stroke rehabilitation patients, practice, and outcomes: Is earlier and more aggressive therapy better? Arch Phys Med Rehabil 86 12 Supplement 2 2005 S101 S114
55. S.D. Horn, and J. Gassaway Practice-based evidence study design for comparative effectiveness research Med Care 45 2007 S50 S57
56. C.C. Hung, M.H. Chiou, B.H. Huang, Y.W. Hsieh, T.J. Hsieh, C.L. Huang, and H.Y. Lane Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients Pharmacogenomics 12 2011 1525 1533
57. Institute of Medicine Relieving pain in America: A blueprint for transforming prevention, care, education, and research 2011 The National Academies Press Washington, DC
58. R.N. Jamison, R.R. Edwards, X. Liu, E.L. Ross, E. Michna, M. Warnick, and A.D. Wasan Relationship of negative affect and outcome of an opioid therapy trial among low back pain patients Pain Pract 2012 Jun 11 [Epub ahead of print]
59. A. Jones, V. Cunningham, S. Ha-Kawa, T. Fujiwara, S. Luthra, S. Silva, S. Derbyshire, and T. Jones Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis Br J Rheumatol 33 1994 909 916
60. A. Jones, N. Kitchen, H. Watabe, V. Cunningham, T. Jones, S. Luthra, and D. Thomas Measurement of changes in opioid receptor binding in vivo during trigeminal neuralgic pain using [11C] diprenorphine and positron emission tomography J Cereb Blood Flow Metab 19 1999 803 808
61. A.K. Jones, H. Watabe, V.J. Cunningham, and T. Jones Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET Eur J Pain 8 2004 479 485
62. E. Kalso, J.E. Edwards, R.A. Moore, and H.J. McQuay Opioids in chronic non-cancer pain: Systematic review of efficacy and safety Pain 112 2004 372 380
63. O. Kambur, and P.T. Männistö Catechol-O-methyltransferase and pain Int Rev Neurobiol 95 2010 227 279
64. M.A. King, S. Bradshaw, A.H. Chang, J.E. Pintar, and G.W. Pasternak Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: Evidence for a tonically active anti-opioid system J Neurosci 21 2011 7788 7792
65. B.M. Kuehn Opioid prescriptions soar: Increase in legitimate use as well as abuse JAMA 17 2007 249 251
66. B.M. Kuehn Efforts aim to curb opioid deaths, injuries JAMA 301 2009 1213 1215
67. D. Kumar, J. Chakraborty, and S. Das Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population Prog Neuropsychopharmacol Biol Psychiatry 36 2012 225 230
68. M.R. Lee, C.L. Gallen, X. Zhang, C.A. Hodgkinson, D. Goldman, E.A. Stein, and C.S. Barr Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans PLoS One 6 2011 e24203
69. L.J. Lesko Personalized medicine: Elusive dream or imminent reality? Clin Pharmacol Ther 81 2007 807 816
70. K. Linde, G. Allais, B. Brinkhaus, E. Manheimer, A. Vickers, and A.R. White Acupuncture for migraine prophylaxis Cochrane Database of Systematic Reviews Issue 1 2009 Art.No.: CD001218
71. J. Lötsch, G. Geisslinger, and I. Tegeder Genetic modulation of the pharmacological treatment of pain Pharmacol Ther 124 2009 168 184
72. J. Maarrawi, R. Peyron, P. Mertens, N. Costes, M. Magnin, M. Sindou, B. Laurent, and L. Garcia-Larrea Differential brain opioid receptor availability in central and peripheral neuropathic pain Pain 127 2007 183 194
73. L. Manchikanti, V. Singh, S. Datta, S.P. Cohen, and J.A. Hirsch American Society of Interventional Pain Physicians. Comprehensive review of epidemiology, scope, and impact of spinal pain Pain Physician 12 2009 E35 E70
74. B.C. Martin, M.Y. Fan, M.J. Edlund, A. Devries, J.B. Braden, and M.D. Sullivan Long-term chronic opioid therapy discontinuation rates from the TROUP study J Gen Intern Med 26 2011 1450 1457
75. J.A. McCubbin, R. Cheung, T.B. Montgomery, R. Bulbulian, and J.F. Wilson Aerobic fitness and opioidergic inhibition of cardiovascular stress reactivity Psychophysiology 29 1992 687 697
76. J.A. McCubbin, J.F. Wilson, S. Bruehl, P. Ibarra, C.R. Carlson, J.A. Norton, and G.W. Colclough Relaxation training and opioid inhibition of blood pressure response to stress J Consult Clin Psychol 64 1996 593 601
77. T.F. Meert, and M. De Kock Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats Anesthesiology 81 1994 677 688
78. B.D. Naliboff, S.M. Wu, B. Schieffer, R. Bolus, Q. Pham, A. Baria, D. Aragaki, W. Van Vort, F. Davis, and P. Shekelle A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain J Pain 12 2011 288 296
79. V. Napadow, J. Kim, D.J. Clauw, and R.E. Harris Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia Arthritis Rheum 64 2012 2398 2403
80. D.A. Nielsen, F. Ji, V. Yuferov, A. Ho, A. Chen, O. Levran, J. Ott, and M.J. Kreek Genotype patterns that contribute to increased risk for or protection from developing heroin addiction Mol Psychiatry 13 2008 417 428
81. M. Niesters, A. Dahan, B. Kest, J. Zacny, T. Stijnen, L. Aarts, and E. Sarton Do sex differences exist in opioid analgesia? A systematic review and meta-analysis of human experimental and clinical studies Pain 151 2010 61 68
82. M. Noble, J.R. Treadwell, S.J. Tregear, V.H. Coates, P.J. Wiffen, C. Akafomo, and K.M. Schoelles Long-term opioid management for chronic noncancer pain. ECRI Institute, 5200 Butler Pike, Plymouth Meeting, PA, USA, 19462 Cochrane Database Syst Rev 1 2010 CD006605
83. E.M. O'Brien, R.M. Staud, A.D. Hassinger, R.C. McCulloch, J.G. Craggs, J.W. Atchison, D.D. Price, and M.E. Robinson Patient-centered perspective on treatment outcomes in chronic pain Pain Med 11 2010 6 15
84. S. Okie A flood of opioids, a rising tide of deaths N Engl J Med 363 2010 1981 1985
85. G. Ozalp, R. Sarioglu, G. Tuncel, K. Aslan, and N. Kadiogullari Preoperative emotional states in patients with breast cancer and postoperative pain Acta Anaesthesiol Scand 47 2003 26 29
86. P.H. Pan, R. Coghill, T.T. Houle, M.H. Seid, W.M. Lindel, R.L. Parker, S.A. Washburn, L. Harris, and J.C. Eisenach Multifactorial preoperative predictors for postcesarean section pain and analgesic requirement Anesthesiology 104 2006 417 425
87. S.D. Passik Issues in long-term opioid therapy: Unmet needs, risks, and solutions Mayo Clin Proc 84 2009 593 601
88. L.J. Paulozzi, D.S. Budnitz, and Y. Xi Increasing deaths from opioid analgesics in the United States Pharmacoepidemiol Drug Saf 15 2006 618 627
89. L.J. Paulozzi, and G.W. Ryan Opioid analgesics and rates of fatal drug poisoning in the United States Am J Prev Med 31 2006 506 511
90. Z.V. Pavlova, K.P. Laktionov, M.E. Isakova, and N.E. Kushlinskii Concentration of β- endorphin in blood plasma and cerebrospinal fluid during various types of anesthesia in the early postoperation period and in incurable oncological patients Bull Exp Biol Med 128 1999 1150 1154
91. P. Petrovic, E. Kalso, K.M. Petersson, and M. Ingvar Placebo and opioid analgesia-imaging a shared neuronal network Science 295 2002 1737 1740
92. V.K. Podichetty, L.T. Weiss, G.J. Fanciullo, and J.C. Baird Web-based health survey systems in outcome assessment and management of pain Pain Med 8 Suppl 3 2007 S189 S198
93. M.C. Reid, D.A. Bennett, W.G. Chen, B.A. Eldadah, J.T. Farrar, B. Ferrell, R.M. Gallagher, J.T. Hanlon, K. Herr, S.D. Horn, C.E. Inturrisi, S. Lemtouni, Y.W. Lin, K. Michaud, R.S. Morrison, T. Neogi, L.L. Porter, D.H. Solomon, M. Von Korff, K. Weiss, J. Witter, and K.L. Zacharoff Improving the pharmacologic management of pain in older adults: Identifying the research gaps and methods to address them Pain Med 12 2011 1336 1357
94. M.E. Robinson, J.L. Brown, S.Z. George, P.S. Edwards, J.W. Atchison, A.T. Hirsh, L.B. Waxenberg, V. Wittmer, and R.B. Fillingim Multidimensional success criteria and expectations for treatment of chronic pain: The patient perspective Pain Med 6 2005 336 345
95. J.P. Schneider, and K.L. Kirsh Defining clinical issues around tolerance, hyperalgesia, and addiction: A quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice J Opioid Manag 6 2010 385 395
96. J. Scholz, R.J. Mannion, D.E. Hord, R.S. Griffin, B. Rawal, H. Zheng, D. Scoffings, A. Phillips, J. Guo, R.J. Laing, S. Abdi, I. Decosterd, and C.J. Woolf A novel tool for the assessment of pain: Validation in low back pain PLoS Med 6 2009 e1000047
97. D.J. Scott, M.M. Heitzeg, R.A. Koeppe, C.S. Stohler, and J.K. Zubieta Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity J Neurosci 26 2006 10789 10795
98. J. Shi, L. Hui, Y. Xu, F. Wang, W. Huang, and G. Hu Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin Hum Mutat 19 2002 459 460
99. H.S. Smith, K.L. Kirsh, and S.D. Passik Chronic opioid therapy issues associated with opioid abuse potential J Opioid Manag 5 2009 287 300
100. T. Sprenger, F. Willoch, M. Miederer, F. Schindler, M. Valet, A. Berthele, M.E. Spilker, S. Förderreuther, A. Straube, I. Stangier, H.J. Wester, and T.R. Tölle Opioidergic changes in the pineal gland and hypothalamus in cluster headache: A ligand PET study Neurology 66 2006 1108 1110
101. I. Steigerwald, M. Müller, A. Davies, D. Samper, R. Sabatowski, R. Baron, S. Rozenberg, A. Szczepanska-Szerej, A. Gatti, and H.G. Kress Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: Results of an open-label, phase 3b study Curr Med Res Opin 28 2012 911 936
102. M.D. Sullivan, M.J. Edlund, M.Y. Fan, A. Devries, J. Brennan Braden, and B.C. Martin Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: The TROUP study Pain 138 2008 440 449
103. M.D. Sullivan, M.J. Edlund, M.Y. Fan, A. Devries, J. Brennan Braden, and B.C. Martin Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study Pain 150 2010 332 339
104. M.D. Sullivan, M.J. Edlund, L. Zhang, J. Unutzer, and K.B. Wells Association between mental health disorders, problem drug use, and regular prescription opioid use Arch Intern Med 166 2006 2087 2093
105. J. Sun, J. Bi, G. Chan, D. Oslin, L. Farrer, J. Gelernter, and H.R. Kranzler Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors Addict Behav 37 2012 1138 1144
106. L.R. Tulner, S.V. Frankfort, G.J. Gijsen, J.P. van Campen, C.H. Koks, and J.H. Beijnen Drug-drug interactions in a geriatric outpatient cohort: Prevalence and relevance Drugs Aging 25 2008 343 355
107. D.C. Turk, K.S. Swanson, and R.J. Gatchel Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis Clin J Pain 24 2008 497 508
108. G.R. Uhl, T. Drgon, C. Johnson, M.F. Ramoni, F.M. Behm, and J.E. Rose Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement Mol Med 16 2010 513 526
109. J. Upadhyay, J. Anderson, R. Baumgartner, A. Coimbra, A.J. Schwarz, G. Pendse, D. Wallin, L. Nutile, J. Bishop, E. George, I. Elman, S. Sunkaraneni, G. Maier, S. Iyengar, J.L. Evelhoch, D. Bleakman, R. Hargreaves, L. Becerra, and D. Borsook Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine Neuroimage 59 2012 3762 3773
110. J. Upadhyay, J. Anderson, A.J. Schwarz, A. Coimbra, R. Baumgartner, G. Pendse, E. George, L. Nutile, D. Wallin, J. Bishop, S. Neni, G. Maier, S. Iyengar, J.L. Evelhoch, D. Bleakman, R. Hargreaves, L. Becerra, and D. Borsook Imaging drugs with and without clinical analgesic efficacy Neuropsychopharmacology 36 2011 2659 2673
111. J. Upadhyay, N. Maleki, J. Potter, I. Elman, D. Rudrauf, J. Knudsen, D. Wallin, G. Pendse, L. McDonald, M. Griffin, J. Anderson, L. Nutile, P. Renshaw, R. Weiss, L. Becerra, and D. Borsook Alterations in brain structure and functional connectivity in prescription opioid-dependent patients Brain 133 2010 2098 2114
112. C.A. von Hehn, R. Baron, and C.J. Woolf Deconstructing the neuropathic pain phenotype to reveal neural mechanisms Neuron 73 2012 638 652
113. T.D. Wager, D.J. Scott, and J.K. Zubieta Placebo effects on human mu-opioid activity during pain Proc Natl Acad Sci USA 104 2007 11056 11061
114. K.J. Wagner, T. Sprenger, E.F. Kochs, T.R. Tölle, M. Valet, and F. Willoch Imaging human cerebral pain modulation by dose-dependent opioid analgesia: A positron emission tomography activation study using remifentanil Anesthesiology 106 2007 548 556
115. C. Walter, and J. Lötsch Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment Pain 146 2009 270 275
116. A.D. Wasan, G. Davar, and R. Jamison The association between negative affect and opioid analgesia in patients with discogenic low back pain Pain 117 2005 450 461
117. H.A. Wijnhoven, H.C. de Vet, and H.S. Picavet Explaining sex differences in chronic musculoskeletal pain in a general population Pain 124 2006 158 166
118. J.C. Willer, D. le Bars, and T. de Broucker Diffuse noxious inhibitory controls in man: Involvement of an opioidergic link Eur J Pharmacol 182 1990 347 355
119. J. Williams, V.L. Haller, D.L. Stevens, and S.P. Welch Decreased basal endogenous opioid levels in diabetic rodents: Effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception Eur J Pharmacol 584 2008 78 86
120. F. Willoch, F. Schindler, H.J. Wester, M. Empl, A. Straube, M. Schwaiger, B. Conrad, and T.R. Tolle Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: A [11C]diprenorphine PET study Pain 108 2004 213 220
121. P.B. Wood, M.F. Glabus, R. Simpson, and J.C. Patterson 2nd Changes in gray matter density in fibromyalgia: Correlation with dopamine metabolism J Pain 10 2009 609 618
122. P.B. Wood, J.C. Patterson 2nd, J.J. Sunderland, K.H. Tainter, M.F. Glabus, and D.L. Lilien Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study J Pain 8 2007 51 58
123. J.W. Younger, L.F. Chu, N.T. D'Arcy, K.E. Trott, L.E. Jastrzab, and S.C. Mackey Prescription opioid analgesics rapidly change the human brain Pain 152 2011 1803 1810
124. V. Yuferov, O. Levran, D. Proudnikov, D.A. Nielsen, and M.J. Kreek Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment Ann N Y Acad Sci 1187 2010 184 207
125. D. Zhang, C. Shao, M. Shao, P. Yan, Y. Wang, Y. Liu, W. Liu, T. Lin, Y. Xie, Y. Zhao, D. Lu, Y. Li, and L. Jin Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population Biol Psychiatry 61 2007 1244 1251
126. J.K. Zubieta, J.A. Bueller, L.R. Jackson, D.J. Scott, Y. Xu, R.A. Koeppe, T.E. Nichols, and C.S. Stohler Placebo effects mediated by endogenous opioid activity on mu-opioid receptors J Neurosci 25 2005 7754 7762